期刊文献+

E1B55kDa缺陷型腺病毒对人肝癌细胞的杀伤研究 被引量:4

Anti-tumor effect of E1B55kDa-deleted adenovirus on human hepatocellular carcinoma cell lines
原文传递
导出
摘要 目的 探讨E1B5 5kDa缺陷型腺病毒dl15 2 0对肝癌细胞的体内外杀伤作用。方法 用dl15 2 0分别感染p5 3基因型不同的人肝癌细胞 ,感染后第 4天用染色的方法检测存活细胞。用RT PCR检测细胞内p5 3和p2 1Waf 1基因表达的改变 ,通过检测腺病毒衣壳蛋白hexon基因的表达证实腺病毒的感染。在SCID裸鼠瘤体内注射dl15 2 0 ,观察dl15 2 0对肝癌细胞的体内杀伤作用。结果 p5 3基因缺失的肝癌细胞Hep3B对dl15 2 0诱导的细胞毒性作用最敏感 ,超过 6 0 %的细胞被杀伤 ,而不足2 0 %的PLC/PRF/ 5 (p5 3基因突变型 )和HepG2 (p5 3基因野生型 )肝癌细胞被杀伤。腺病毒感染后 ,HepG2细胞内p5 3和p2 1Waf 1基因表达水平均明显升高。瘤体内注射dl15 2 0 ,可显著抑制Hep3B裸鼠移植瘤的生长 ,而对PLC/PRF/ 5和HepG2的裸鼠移植瘤则无明显的生长抑制作用。结论 E1B5 5kDa缺失的腺病毒可以选择性地杀伤p5 3基因缺失的肝癌细胞 ,是一种潜在的肿瘤治疗手段。 Objective To investigate the in vitro and in vivo anti tumoral effect of E1B55kDa deleted adenovirus (dl1520) on human hepatocellular carcinoma (HCC) cell lines.Methods Human HCC cell lines with different p53 genotypes were infected with dl1520. Four days after infection, the percentage of survival cells was determined by colorimetric assay. RT polymerase chain reaction (PCR) was used to examine alterations of p53 and p21 Waf 1 expression. Adenovirus hexon gene expression was applied to prove the presence of adenovirus infections. Effects on vivo anti tumor dl1520 were examined with intra tumor injection of dl1520 in the SCID mice.Results After the infection, the p53 null HCC cell line, Hep3B was most vulnerable to dl1520 induced cytotoxic effect with a cell death rate of more than 60%. Whereas, less than 20% PLC/PRF/5 (p53 mutant) and HepG2 (p53 wild type) HCC cell lines were killed. The expression of p53 and p21 Waf 1 was considerably enhanced after the dl1520 infection in HepG2. The intra tumor injection of dl1520 significantly reduced the tumor growth in Hep3B xenografts. In contrast, no obvious tumor repression was observed in HepG2 and PLC/PRF/5 xenografts.Conclusion dl1520 selectively kills the p53 null hepatocellular carcinoma, showing potential application for cancer treatment. [
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2001年第5期366-368,共3页 Chinese Journal of Oncology
关键词 腺病毒 肝细胞癌 P53基因 E1B55kDa缺陷型 基因缺失 Adenovirus Carcinoma, hepatocellular p53 gene
  • 相关文献

参考文献9

  • 1Bischoff J R,Kirn D H,Williams A,et al.An Adenovirus Mutant That Replicates Selectively in p53-Deficient Human Tumor Cells[].Science.1996
  • 2Hall AR,Dix BR,O′Carroll SJ,et al.p53-dependent cell death/apoptosis is required for a productive adenovirus infection[].Nature Medicine.1998
  • 3Goodrum F D,Ornelles D A.p53 status does not determine outcome of E1B 55-kilodalton mutant adenovirus lytic infection[].Journal of Virology.1998
  • 4Rothmann T,Hengstermann A,Whitaker NJ,et al.Replication of ONYX-015, a potential anticancer adenovirus, is independent of p53 status in tumor cells[].Journal of Virology.1998
  • 5Vollmer C M,Ribas A,Butterfield L H,et al.p53 selective and nonselective replication of an E1B- deleted adenovirus in hepatocellular carcinoma[].Cancer Research.1999
  • 6Craig C,Wersto R,Kim M,et al.A recombinant adenovirus expressing p27Kip1 induces cell cycle arrest and loss of cyclin-Cdk activity in human breast cancer cells[].Oncegene.1997
  • 7Alemany R,Balague C,Curiel DT.Replicative adenoviruses for cancer therapy[].Nat Biol.2000
  • 8Coffey M C,Strong J E,Forsyth P A,et al.Reovirus therapy of tumors with activated Ras pathway[].Science.1998
  • 9Stojdl DF,Lichty B,Knowles S,et al.Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus[].Nature Medicine.2000

同被引文献20

  • 1张霞,赵健,王皓,丛文铭,吴孟超,郭亚军.TIP30基因在肝癌组织中的表达及意义[J].中华肝胆外科杂志,2004,10(10):678-678. 被引量:9
  • 2WeiLu,ShuZheng,Xu-FengLi,Jian-JinHuang,XiaoZheng,ZhenLi.Intra-tumor injection of H101,a recombinant adenovirus,in combination with chemotherapy in patients with advanced cancers:A pilot phase Ⅱ clinical trial[J].World Journal of Gastroenterology,2004,10(24):3634-3638. 被引量:20
  • 3Kohn EC, Liotta LA. Molecular insights into cancer invasion:strategies for prevention and intervention[J]. Cancer Res, 1995, 55(9):1856~1862.
  • 4Lu Z, Jiang GQ, Blume-Jensen P, et al. Epidermal Growth Factor-Induced Tumor Cell Invasion and Metastasis Initiated by Dephosphorylation and Downregulation of Focal Adhesion Kinase[J]. Mol Cell Bio, 2001, 21(12):4016~4031.
  • 5Huang JZ, Frischer JS, Serur A, et al. Regression of established tumors and metastases by potent vascular endothelial growth factor blockade[J]. PNAS, 2003, 100(13):7785~7790.
  • 6Shtivelman E. a link between metastasis and resistance to apoptosis of variant small cell lung carcinoma [J]. Oncogene, 1997, 14(18) :2167 ~2173.
  • 7Jiang C, Ito M, Piening V, et al. TIP30 Interacts with an Estrogen Receptor interacting Coactivator CIA and Regulates c-myc Transcription[J].J Biol Chem, 2004, 279(26):27781~27789.
  • 8King FW, Shtivelman E. Inhibition of Nuclear Import by the Proapoptotic Protein CC3 [J]. Mol Cell Bio, 2004, 24 (16):7091 ~7101.
  • 9Liu Y, Thor A, Shtivelman E, et al. Systemic gene delivery expands the repertoire of effective antiangiogenic agents [J]. J Biol Chem, 1999, 274(19):13338~13344.
  • 10Ito M, Jiang C, Krumm K, et al. TIP30 Deficiency Increases Susceptibility to Tumorigenesis [J]. Cancer Res, 2003, 63 (24):8763~8767.

引证文献4

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部